Pathologists Will Benefit from Cancer Research to Describe 50 Tumor Types

Goal is to map genetic, transcriptomic, and epigenomic changes in various cancer types Surgical pathologists are likely to gain great benefit from a worldwide research collaboration that has $500 million in funding, and whose participants plan to identify and publish data about the genetic complexities involved in at least 50 different types of tumors. It is a research project that will directly contribute to the development of new and more precise clinical laboratory tests. This research is...

More Community Hospital Pathology Laboratories Are Ready to Tackle Molecular Testing for Infectious Disease and Cancer

Clinical pathology laboratories often find it difficult to get accurate information about various molecular and genetic assays Because of advances in automated molecular systems and less complex technologies, it is now possible for more clinical pathology laboratories in community hospitals to establish their own molecular diagnostics testing program. This is particularly true of testing for infectious disease and cancer. At the same time that local pathology and clinical laboratories have...

New Twist for Pathology Laboratories: Genetic Cancer Test for Dogs

OncoPet Diagnostics hopes to create revenue stream while testing human RECAF technology Genetic cancer testing for dogs is now available. A clinical pathology laboratory in Canada performs the tests on specimens referred by veterinarians. The molecular diagnostics test for dogs uses a blood specimen and can detect 85% of canine cancers. Pre-market studies showed the standard 95% specificity level. Owners of the 72 million pet dogs in the United States are often as anguished over possible...

Quintiles Expands Its China Laboratory Services to Include Anatomic Pathology Tests

CRO Company Adds Anatomic Pathology Testing Services to Serve China’s Pharma and Biotech Industries Quintiles announced that its Beijing medical laboratory will offer an enhanced menu of anatomic pathology testing services to the Chinese biopharmaceutical industry. With this action, global CRO (clinical research organization) giant Quintiles is responding to the increasing sophistication of the pharmaceutical industry in the world’s most populous country. Quintiles says the new service will...

New Technology Captures Tumor Cells from the Bloodstream

Nano-technology Breakthrough May Prevent Cancers from Metastasizing With the goal of removing tumor cells from the bloodstream, a biomedical engineering team at the University of Arkansas for Medical Sciences (UAMS) in Little Rock has discovered a non-invasive way to identify cancer and to capture tumor cells in the bloodstream. This landmark discovery, could dramatically improve early cancer diagnosis and prevent deadly metastasis. It could also provide a framework for a new type of...
;